Superworth

Airsculpt Technologies price to sales ratio AIRS

Market value divided by revenue over the last twelve months, since 2022.

Today, Nov 2, 2026
0.8×
4-year median
1.7×
Against its 4-year history
6th
percentile: 0 is its lowest day, 100 its highest
4-year range
0.6× to 4.3×
Peer median
2.2×

Airsculpt Technologies' price to sales ratio is 0.8× as of Nov 2, 2026.

That is below its 4-year median of 1.7×, lower than on 94% of days in the last 4 years.

Over that time it ranged from 0.6× in Apr 2025 to 4.3× in Oct 2025.

The median for 4 hospital and care facility stocks of a similar size is 2.2×.

Price to sales ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far0.8×0.6×2.5×
20250.8×0.6×4.3×
20241.7×1.0×2.7×
20232.3×1.4×3.1×
20221.3×1.1×1.3×

Against its peers

Companies in Medical - Care Facilities nearest Airsculpt Technologies' size, closest first, today.

CompanyPrice to sales ratio
AIRSAirsculpt Technologies0.8×
CYHCommunity Health Systems0.0×
VMDViemed Healthcare1.2×
SBCSBC Medical3.1×
OMDAOmada Health3.5×
Peer median2.2×

Where Airsculpt Technologies ranks

What the price to sales ratio tells you

Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.

Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.

More on Airsculpt Technologies

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.